NCT02175238View on ClinicalTrials.gov

Relative Bioavailability of BI 691751 Administered With and Without Food to Healthy Male Subjects

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Healthy
Interventions
DRUG

BI 691751 fasted

single dose BI 691751 in fasted state

DRUG

BI 691751 after high fat breakfast

single dose BI 691751 after a standardised high fat breakfast

Trial Locations (1)

Unknown

1334.28.01001 Boehringer Ingelheim Investigational Site, Madison

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02175238 - Relative Bioavailability of BI 691751 Administered With and Without Food to Healthy Male Subjects | Biotech Hunter | Biotech Hunter